Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_provenance.
- NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_assertion description "[In 8907 stable CAD patients from the EUROPA trial, 52 haplotype-tagging single-nucleotide polymorphisms (SNPs) in 12 candidate genes within the RAAS and kallikrein-bradykinin pathways were investigated for association with hypertension (defined as BP ?160/95 mmHg or use of antihypertensives) and BP response to ACE inhibitors, during a 4-week run-in period.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_provenance.
- NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_assertion evidence source_evidence_literature NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_provenance.
- NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_assertion SIO_000772 21157371 NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_provenance.
- NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_assertion wasDerivedFrom befree-2016 NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_provenance.
- NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_assertion wasGeneratedBy ECO_0000203 NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_provenance.
- befree-2016 importedOn "2016-02-19" NP859069.RAAcIO6DJPFNxs1UWIlnZMYwxW30cX-wBC3NU87a9C7DI130_provenance.